{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:36:00Z","timestamp":1770744960894,"version":"3.49.0"},"reference-count":66,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2007,3,12]],"date-time":"2007-03-12T00:00:00Z","timestamp":1173657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:sec><jats:title>summary<\/jats:title><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>The concept of augmenting the management of irritable bowel syndrome with antibiotics is evolving, and many questions remain regarding this therapy relative to known and hypothesized irritable bowel syndrome pathophysiology. The clinical evidence of small intestinal bacterial overgrowth as an important aetiology of irritable bowel syndrome continues to accumulate. Clinical symptoms of bacterial overgrowth and irritable bowel syndrome are similar; however, a definitive cause\u2010and\u2010effect relationship remains unproven. It is unclear whether motility dysfunction causes bacterial overgrowth or gas products of enteric bacteria affect intestinal motility in irritable bowel syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To discusses the efficacy and tolerability of current symptom\u2010directed pharmacotherapies and of antibiotics in the treatment of irritable bowel syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A computerized search of PubMed was performed with search terms \u2018IBS\u2019, \u2018pharmacotherapy\u2019 and \u2018antibiotics\u2019. Relevant articles were selected, and the reference list of selected articles was reviewed to identify additional references.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Antibiotic treatment benefits a subset of irritable bowel syndrome patients. The non\u2010absorbed antibiotic rifaximin has a favourable safety and tolerability profile compared with systemic antibiotics and demonstrates a therapeutic efficacy comparable with symptom\u2010based irritable bowel syndrome pharmacotherapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Rifaximin is the only antibiotic with demonstrated sustained benefit beyond therapy cessation in irritable bowel syndrome patients in a placebo\u2010controlled trial. Whether antibiotics can improve quality of life in patients with irritable bowel syndrome warrants further research.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2007.03313.x","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T11:27:11Z","timestamp":1279884431000},"page":"1271-1281","source":"Crossref","is-referenced-by-count":41,"title":["Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome"],"prefix":"10.1111","volume":"25","author":[{"given":"C. L.","family":"FRISSORA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. D.","family":"CASH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,3,12]]},"reference":[{"key":"e_1_2_6_2_2","volume-title":"Rome II: The Functional Gastrointestinal Disorders","author":"Drossman DA","year":"2000"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2005.02.010"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2005.02.007"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2005.02.003"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00160.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000007593"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1994.tb01115.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-005-0016-y"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-003-0035-5"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2004.04.008"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07306.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2005.02.002"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-2-200007180-00013"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02294.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000139029.00451.c7"},{"key":"e_1_2_6_17_2","first-page":"71","article-title":"Diagnosis, treatment, and management of irritable bowel syndrome with constipation and chronic constipation","volume":"7","author":"Frissora CL","year":"2005","journal-title":"MedGenMed"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01347.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30509.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.7.852"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00626-3"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2005.00650.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra035579"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.5.671"},{"key":"e_1_2_6_25_2","first-page":"276","article-title":"Irritable colon syndrome treated with an antispasmodic drug","volume":"217","author":"Wheatley D","year":"1976","journal-title":"Practitioner"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198106000-00009"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6160.376"},{"key":"e_1_2_6_28_2","first-page":"488","article-title":"Behandlung des colon irritable [The treatment of irritable colon: efficacy and tolerance of buscopan plus, buscopan, paracetamol and placebo in ambulatory patients with irritable colon]","volume":"108","author":"Schafer E","year":"1990","journal-title":"Fortschr Med"},{"key":"e_1_2_6_29_2","first-page":"CD003460","article-title":"Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome","volume":"2","author":"Quartero AO","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_30_2","first-page":"S7","article-title":"Systematic review on the management of irritable bowel syndrome in North America","volume":"11","author":"Brandt LJ","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_31_2","first-page":"736","article-title":"Antidepressants in the treatment of irritable bowel syndrome and visceral pain syndromes","volume":"5","author":"Crowell MD","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00669-3"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00299-5"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02267.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0269-2813.2004.01862.x"},{"issue":"1","key":"e_1_2_6_36_2","first-page":"S1","article-title":"An evidence\u2010based approach to the management of chronic constipation in North America","volume":"100","author":"American College of Gastroenterology Chronic Constipation Task Force","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296258"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528709091004"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609006766"},{"key":"e_1_2_6_40_2","first-page":"CD003960","article-title":"Tegaserod for the treatment of irritable bowel syndrome","volume":"1","author":"Evans BW","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.070789"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00459.x"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2982.2003.00389.x"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02033-X"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.14.1733"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.04128.x"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03368.x"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02493.x"},{"key":"e_1_2_6_49_2","first-page":"412","article-title":"Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double\u2010blind, randomized, placebo\u2010controlled study","volume":"98","author":"Pimentel M","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.011502"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.40795.x"},{"key":"e_1_2_6_52_2","first-page":"17","article-title":"Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations","volume":"7","author":"Noddin L","year":"2005","journal-title":"MedGenMed"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.11.050"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mog.0000194792.36466.5c"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1086\/432956"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9104-6"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00751.x"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02516.x"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006058801600410"},{"key":"e_1_2_6_60_2","first-page":"W1732","volume-title":"Gastroenterology","author":"Baidoo LR","year":"2006"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00808.x"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00458.x"},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-8-200610170-00004"},{"key":"e_1_2_6_64_2","first-page":"89","article-title":"Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin","volume":"52","author":"Cuoco L","year":"2006","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"2","key":"e_1_2_6_65_2","article-title":"An open\u2010label pilot trial of high\u2010dose rifaximin in the treatment of patients with constipation\u2010predominant irritable bowel syndrome (abstract T1287)","volume":"130","author":"George G","year":"2006","journal-title":"Gastroenterology"},{"key":"e_1_2_6_66_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565120-00011"},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629030-00004"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2007.03313.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2007.03313.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T23:37:44Z","timestamp":1697240264000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2007.03313.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,12]]},"references-count":66,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1111\/j.1365-2036.2007.03313.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03313.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,12]]}}}